NCT04313972View on ClinicalTrials.gov

IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone

PHASE4TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

January 23, 2023

Study Completion Date

February 23, 2023

Conditions
Interstitial CystitisPainful Bladder SyndromeBladder Pain SyndromeLow Dose NaltrexoneLow-dose NaltrexoneNaltrexone
Interventions
DRUG

low-dose naltrexone

2mg of low-dose naltrexone nightly for 2 weeks, then 4mg of low-dose naltrexone nightly for 4 weeks

DRUG

Placebo oral tablet

1 capsule nighty for 2 weeks, then 2 capsules nightly for 4 weeks

Trial Locations (1)

60076

Center for Pelvic Health at the NorthShore University HealthSystem, Skokie

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
lead

Endeavor Health

OTHER